| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AHJ.2010.05.004 |
| P8608 | Fatcat ID | release_k6kz462csjf6fmxqfayc5kntmm |
| P932 | PMC publication ID | 2897833 |
| P698 | PubMed publication ID | 20598978 |
| P5875 | ResearchGate publication ID | 45090115 |
| P50 | author | Francesca Bursi | Q98213548 |
| Véronique L. Roger | Q110955107 | ||
| Susan A. Weston | Q114360421 | ||
| Jill M. Killian | Q114361269 | ||
| P2093 | author name string | Robert Vassallo | |
| P2860 | cites work | Mortality in relation to smoking: 40 years' observations on male British doctors | Q24648574 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary | Q29614692 | ||
| Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study | Q34326181 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature | Q36157802 | ||
| Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease | Q36162987 | ||
| Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality | Q36236967 | ||
| Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. | Q36605498 | ||
| Pulmonary diseases and the heart | Q37034777 | ||
| Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). | Q37102979 | ||
| A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. | Q37189094 | ||
| Uncontrolled immune response in acute myocardial infarction: unraveling the thread. | Q37334566 | ||
| Spirometry utilization after hospitalization for patients with chronic obstructive pulmonary disease exacerbations | Q37367166 | ||
| Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease | Q44358876 | ||
| Coronary artery bypass grafting in patients with COPD. | Q44840068 | ||
| Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers | Q46375440 | ||
| Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease | Q48016346 | ||
| Symptoms of chronic bronchitis and the risk of coronary disease. | Q50536631 | ||
| External Validity of Clinical Trials in Acute Myocardial Infarction | Q57243471 | ||
| C-Reactive Protein and Heart Failure after Myocardial Infarction in the Community | Q57540166 | ||
| Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994 | Q57540371 | ||
| From COPD to chronic systemic inflammatory syndrome? | Q58877168 | ||
| Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group | Q67967182 | ||
| Death certificate reporting of confirmed airways obstructive disease | Q70143034 | ||
| Smoking and lung function in elderly men and women. The Cardiovascular Health Study | Q70712911 | ||
| Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73088403 | ||
| Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction | Q79761190 | ||
| Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes | Q79817388 | ||
| Coronary disease surveillance: a public heath imperative | Q80755663 | ||
| Chronic obstructive pulmonary disease | Q93936786 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 95-101 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Chronic obstructive pulmonary disease after myocardial infarction in the community | |
| P478 | volume | 160 |
| Q37644823 | Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links |
| Q38688695 | Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period |
| Q55381292 | Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes. |
| Q38111151 | Chronic obstructive pulmonary disease and cardiovascular disease |
| Q38342003 | Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management |
| Q28646419 | Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease |
| Q28660388 | Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records |
| Q88536449 | Evaluation for airway obstruction in adult patients with stable ischemic heart disease |
| Q34304837 | Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction |
| Q37964807 | Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice |
| Q64118155 | New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease |
| Q54325324 | Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention. |
| Q28596228 | Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease |
| Q44774640 | Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study |
| Q33709381 | Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan |
| Q38553747 | Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q26781406 | Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis |
| Q26795662 | Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities |
| Q35802189 | Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial |
| Q35871744 | Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study |
| Q36085731 | β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study. |
Search more.